MNIMBS

In the News

March 13, 2008 - “Nanotechnology approach shows promise with vaccines,” Ann Arbor Business Review

March 10, 2008 - Dr. James R. Baker Jr. has been named the Distinguished University Innovator for 2008. Baker, a scientist in the Medical School and a successful entrepreneur, has conducted breakthrough research in nanotechnology materials and launched two startup companies based on the results. The Univesrity Record

March 4, 2008 - “A New Approach to Combatting HIV: High-tech solutions of oil in water could lead to an effective HIV vaccine,” Technology Review


February 26, 2008 - Nanoemulsion vaccines show increasing promise as effective protection against viral diseases.
U-M studies in mice of oil-based nasal vaccine technology show effective immunity against smallpox and HIV.  A novel technique for vaccinating against a variety of infectious diseases – using an oil-based emulsion placed in the nose, rather than needles – has proved able to produce a strong immune response against smallpox and HIV in two new studies

January 23, 2008 - M-NIMBS Symposium on Nanotechnology Approaches to Genetic Diagnostics
On Monday afternoon, March 31, 2008, we held our endowed Nanotechnology Symposium named in honor of one of our benefactors, Mr. Herbert D. Doan, the former Chairman of the Dow Chemical Company. Speakers reflecting the cross-disciplinary nature of the Institute included : Charles Cantor, Ph.D. Chief Scientific Officer, Sequenom, San Diego, CA and James W. Schneider, PhD, Associate Professor of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA.

August 16, 2007 - Anthrax vaccine uses nanoparticles to produce immunity
A nasal vaccine shows strong promise in initial animal studies conducted by U-M researchers at the Michigan Nanotechnology Institute for Medicine and the Biological Sciences. After further studies in animals and people, the result could be a better anthrax vaccine that requires no shots, is effective with only one or two immunizations, needs no refrigeration and could be used effectively after a bioterrorism attack to boost immune response in exposed people.

Hybrid Gold-Dendrimer Nanoparticles Target and Image Tumors

Dead On Target: Multifunctional Nanoparticle Platforms For Targeting And Imaging Cancer Cells

Fighting cancer from the inside out
At the University of Michigan Nanotechnology Institute, a nanotechnology equivalent of a Trojan Horse has been created to smuggle a powerful chemotherapy drug inside a cancer tumor cell, increasing the drugs cancer-killing ability. While it is still in the experimental stages, this technology holds great promise to revolutionize medicine

Nanotech Delivers Cancer treatment: Cancer therapeutic targets directly to cancer cells. University of Michigan scientists have created the nanotechnology equivalent of a Trojan horse to smuggle a powerful chemotherapeutic drug inside tumor cells - increasing the drug's cancer-killing activity and reducing its toxic side effects.

UM Project Funded by DARPA: Battlefield Analgesics with Physiological Feedback Control...

Paper on Pulse Shaping Tops the Competition:"Increasing two-photon fluorescence signals by coherent control"...

Nanotech Delivers Cancer Treatment: Cancer therapeutic targets directly to cancer cells...

Bill & Melinda Gates Foundation Grant : M-NIMBS is one of 43 institutions to receive a Grand Challenges in Global Health Initiative grant...

U-M project funded by Gates Foundation: Development of a needle-free nanoemulsion-based vaccine delivery system for Hepatitis B...

NASA Biosensors
Biosensors detecting radiation exposure on the fly by looking for individual cells that have been harmed.

Grand Challenges in Global Health Initiative Selects 43 Groundbreaking Research Projects for More Than $436 Million in Funding
Scientists around the world to discover new ways to fight disease in poorest countries.

Nanoparticles transport cancer-killing drug into tumor cells to increase efficacy, lower drug toxicity in mice
U-M scientists use folic acid as bait to get methotrexate inside tumor cells.

Nano Trojan horse for chemotherapy
University of Michigan scientists have created the nanotechnology equivalent of a Trojan horse to smuggle a powerful chemotherapeutic drug inside tumor cells - increasing the drug's cancer-killing activity and reducing its toxic side effects.

Nanotechnology - An Engineering Response to Human Problems
Some of the many current investigations into nanotechnology having the objective of helping to improve people's lives in areas such as healthcare, the environment, energy, homeland security and manufacturing.

 

BlueLine

© The Michigan Nanotechnology Institute for Medicine and Biological Sciences (M-NIMBS)® 2008
M-NIMBS is a registered trademark of The Michigan Nanotechnology Institute for Medicine and Biological Sciences.
M-NIMBS logo and graphic designed by Paul D. Trombley, website by Mellon & Associates, LLC
All other company, brand, and product names are or may be trademarks of their respective holders.